Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection
- 744 Downloads
The role of human papillomavirus (HPV) on head and neck squamous cell carcinoma (HNSCC) survival in regions with low HPV prevalence is not yet clear. We evaluated the HPV16 infection on survival of HNSCC Brazilian patient series.
This cohort comprised 1,093 HNSCC cases recruited from 1998 to 2008 in four Brazilian cities and followed up until June 2009. HPV16 antibodies were analyzed by multiplex Luminex assay. In a subset of 398 fresh frozen or paraffin blocks of HNSCC specimens, we analyzed for HPV16 DNA by L1 generic primer polymerase chain reaction. HNSCC survival according to HPV16 antibodies was evaluated through Kaplan–Meier method and Cox regression.
Prevalence of HPV16 E6 and E6/E7 antibodies was higher in oropharyngeal cancer than in other head and neck tumor sites. HPV16 DNA positive in tumor tissue was also higher in the oropharynx. Seropositivity for HPV16 E6 antibodies was correlated with improved HNSCC survival and oropharyngeal cancer. The presence of HPV16 E6/E7 antibodies was correlated with improved HNSCC survival and oropharyngeal cancer survival. The death risk of oropharyngeal squamous cell carcinoma patients HPV16 E6/E7 antibodies positive was 78 % lower than to those who test negative.
Oropharyngeal squamous cell carcinoma is less aggressive in the HPV16 E6/E7 positive serology patients. HPV16 E6/E7 antibody is a clinically sensible surrogate prognostic marker of oropharyngeal squamous cell carcinoma.
KeywordsHuman papillomavirus Serology Prognosis Head and neck cancer Prevalence
This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) [10/50733-6; 09/52031-1 and 04/12054-9] and by the European Commission [IC18-CT97-0222].
Conflict of interest
- 2.Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No 10 [Internet]. Lyon, France: International Agency for Research on Cancer; [cited 2012 Aug 30]. http://globocan.iarc.fr
- 5.Human papillomaviruses (2007) Lyon, France: International Agency for Research on Cancer- IARC Monograph on the Evaluation of Carcinogenic Risks to HumansGoogle Scholar
- 15.World Health Organization (1992) International statistical classification of diseases and related health problems. 10th rev. World Health Organization, Washington, DCGoogle Scholar
- 16.Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP et al (2007) Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 99:777–789PubMedCrossRefGoogle Scholar
- 17.Sobin LH, Wittekind C (2002) TNM classification of malignant tumours. International Union Against Cancer, 6th edn. Wiley-Liss, New YorkGoogle Scholar
- 18.Kleter B, Van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, Ter Schegget J et al (1999) Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 37:2508–2517PubMedCentralPubMedGoogle Scholar
- 20.Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H et al (1994) Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infec Dis 170:1077–1085CrossRefGoogle Scholar